Sorry, your browser does not support JavaScript!
Medicine Questions
Report an Adverse Event
Investors
Contact
Global Operations
North America
Canada
Mexico
USA
South America
Argentina
Brazil
Asia
China Mainland
Hong Kong
India
Japan
Korea
Singapore
Taiwan
Middle East
Israel
Saudi Arabia
Türkiye
United Arab Emirates
Africa
South Africa
Australia
Australia and New Zealand
Europe
Austria
Belgium and Luxembourg
Czech Republic & Slovakia
Denmark
Finland
France
Germany
Greece
Iceland
Ireland
Italy
Netherlands
Norway
Poland & The Baltics
Portugal
Romania
Russia
Spain
Sweden
Switzerland
United Kingdom
Our Company
About Us
Leadership
U.S. Public Policy Engagement
Policies and Disclosures
Supplier Information
U.S. Locations
Our Purpose
Partnerships and Community
Corporate Giving
Gilead Foundation
Inclusion and Diversity
Environmental, Social, Governance (ESG)
Sustainability
Advancing Global Health
Medication Access
Science & Medicine
Our Therapeutic Areas
Medicines
Pipeline
Research
Clinical Trials
News and Press
Events
Stories
Newsroom
Company Statements
Annual Reports
Careers
Careers at Gilead
Our Culture
Meet Our Employees
Inclusion and Diversity in Hiring
Compensation, Benefits and Wellbeing
Our Global Footprint
Early Career Opportunities
Postdoctoral Fellowships
Hiring Events
Talent Community Sign-up
Utility
Privacy Statements
Terms Of Use
Social Media Guidelines
Sitemap
BACK TO MAIN MENU
Leadership
Governance and Committees
BACK TO MAIN MENU
U.S. Public Policy Engagement
Political Contributions Archives
BACK TO MAIN MENU
Policies and Disclosures
Policies
Disclosures
BACK TO MAIN MENU
Supplier Information
Supplier Enablement Resources
Supplier Inclusion
BACK TO MAIN MENU
Partnerships and Community
COMPASS Initiative
HepConnect
HIV Age Positively
Toward Health Equity for Black People Impacted by TNBC
Toward Health Equity Oncology Grant
RADIAN
TRANScend
Zeroing In: Ending the HIV Epidemic
Zeroing In: Latin America & The Caribbean (LAC) Region
BACK TO MAIN MENU
Corporate Giving
What We Fund
Funding Requests
BACK TO MAIN MENU
Gilead Foundation
Creating Possible Fund
BACK TO MAIN MENU
Environmental, Social, Governance (ESG)
Reporting
U.N. Global Compact
U.N. Sustainable Development Goals
BACK TO MAIN MENU
Sustainability
Our Business Is Sustainable
Performance
BACK TO MAIN MENU
Advancing Global Health
COVID-19
HCV Elimination
BACK TO MAIN MENU
Medication Access
U.S. Patient Access
Global Access
Authorized Distributors
BACK TO MAIN MENU
Our Therapeutic Areas
Virology
Oncology
Inflammation
BACK TO MAIN MENU
Research
Research Scholars Program
Compassionate Use
Community Based Participatory Research (CBPR)
Investigator-Sponsored Research
BACK TO MAIN MENU
Newsroom
Press Releases
Media Inquiries
BACK TO MAIN MENU
Early Career Opportunities
Internship Program
BACK TO MAIN MENU
Privacy Statements
Cookie Statement
Global Applicant Privacy Statement
Healthcare Professional Privacy Notice - U.S. only
Healthcare Professional Privacy Notice
BACK TO MAIN MENU
North America
Canada
Mexico
USA
South America
Argentina
Brazil
Asia
China Mainland
Hong Kong
India
Japan
Korea
Singapore
Taiwan
Middle East
Israel
Saudi Arabia
Türkiye
United Arab Emirates
Africa
South Africa
Australia
Australia and New Zealand
Europe
Austria
Belgium and Luxembourg
Czech Republic & Slovakia
Denmark
Finland
France
Germany
Greece
Iceland
Ireland
Italy
Netherlands
Norway
Poland & The Baltics
Portugal
Romania
Russia
Spain
Sweden
Switzerland
United Kingdom
BACK TO MAIN MENU
Contact
Request Medicines Information
Report an Adverse Event
Partnership Request
Search Term
Medicine Questions
Report an Adverse Event
Investors
Contact
Global Operations
Toggle Inner Dropdown
BACK TO MAIN MENU
Google.com
Vermont Disclosures
Vermont
Headline
Close
×
Intersititial body copy
